These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Ebola Virus Makona Shows Reduced Lethality in an Immune-deficient Mouse Model. Smither SJ; Eastaugh L; Ngugi S; O'Brien L; Phelps A; Steward J; Lever MS J Infect Dis; 2016 Oct; 214(suppl 3):S268-S274. PubMed ID: 27471321 [TBL] [Abstract][Full Text] [Related]
25. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein. Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532 [TBL] [Abstract][Full Text] [Related]
26. Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics Platform. Cnops L; Van den Eede P; Pettitt J; Heyndrickx L; De Smet B; Coppens S; Andries I; Pattery T; Van Hove L; Meersseman G; Van Den Herrewegen S; Vergauwe N; Thijs R; Jahrling PB; Nauwelaers D; Ariën KK J Infect Dis; 2016 Oct; 214(suppl 3):S192-S202. PubMed ID: 27247341 [TBL] [Abstract][Full Text] [Related]
27. Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material. Trefry JC; Wollen SE; Nasar F; Shamblin JD; Kern SJ; Bearss JJ; Jefferson MA; Chance TB; Kugelman JR; Ladner JT; Honko AN; Kobs DJ; Wending MQ; Sabourin CL; Pratt WD; Palacios GF; Pitt ML Viruses; 2015 Dec; 7(12):6739-54. PubMed ID: 26703716 [TBL] [Abstract][Full Text] [Related]
28. Development of a murine model for aerosolized ebolavirus infection using a panel of recombinant inbred mice. Zumbrun EE; Abdeltawab NF; Bloomfield HA; Chance TB; Nichols DK; Harrison PE; Kotb M; Nalca A Viruses; 2012 Dec; 4(12):3468-93. PubMed ID: 23207275 [TBL] [Abstract][Full Text] [Related]
29. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. Callendret B; Vellinga J; Wunderlich K; Rodriguez A; Steigerwald R; Dirmeier U; Cheminay C; Volkmann A; Brasel T; Carrion R; Giavedoni LD; Patterson JL; Mire CE; Geisbert TW; Hooper JW; Weijtens M; Hartkoorn-Pasma J; Custers J; Grazia Pau M; Schuitemaker H; Zahn R PLoS One; 2018; 13(2):e0192312. PubMed ID: 29462200 [TBL] [Abstract][Full Text] [Related]
30. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs. Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337 [TBL] [Abstract][Full Text] [Related]
31. Delayed Disease in Cynomolgus Macaques Exposed to Ebola Virus by an Intranasal Route. Johnston SC; Wilhelmsen CL; Shamblin J; Kimmel A; Zelko J; Wollen S; Goff AJ Front Immunol; 2021; 12():709772. PubMed ID: 34484210 [TBL] [Abstract][Full Text] [Related]
32. Implementation of a non-human primate model of Ebola disease: Infection of Mauritian cynomolgus macaques and analysis of virus populations. Piorkowski G; Jacquot F; Quérat G; Carbonnelle C; Pannetier D; Mentré F; Raoul H; de Lamballerie X Antiviral Res; 2017 Apr; 140():95-105. PubMed ID: 28132865 [TBL] [Abstract][Full Text] [Related]
33. Transmission of Ebola virus from pigs to non-human primates. Weingartl HM; Embury-Hyatt C; Nfon C; Leung A; Smith G; Kobinger G Sci Rep; 2012; 2():811. PubMed ID: 23155478 [TBL] [Abstract][Full Text] [Related]
34. Characterization of clinical and immunological parameters during Ebola virus infection of rhesus macaques. Martins K; Cooper C; Warren T; Wells J; Bell T; Raymond J; Stuthman K; Benko J; Garza N; van Tongeren S; Donnelly G; Retterer C; Dong L; Bavari S Viral Immunol; 2015 Feb; 28(1):32-41. PubMed ID: 25514385 [TBL] [Abstract][Full Text] [Related]
35. Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses. Frei JC; Nyakatura EK; Zak SE; Bakken RR; Chandran K; Dye JM; Lai JR Sci Rep; 2016 Jan; 6():19193. PubMed ID: 26758505 [TBL] [Abstract][Full Text] [Related]
36. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection. Geisbert TW; Strong JE; Feldmann H J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223 [TBL] [Abstract][Full Text] [Related]
37. Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques. Wong G; Qiu X; de La Vega MA; Fernando L; Wei H; Bello A; Fausther-Bovendo H; Audet J; Kroeker A; Kozak R; Tran K; He S; Tierney K; Soule G; Moffat E; Günther S; Gao GF; Strong J; Embury-Hyatt C; Kobinger G J Infect Dis; 2016 Oct; 214(suppl 3):S281-S289. PubMed ID: 27651412 [TBL] [Abstract][Full Text] [Related]